Octreotide acetate Prescribing at WORTHING MEDICAL GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
14
Total Quantity
830
NHS Cost
£6.1K
vs National Avg
+125.3%
WORTHING MEDICAL GROUP prescribed 14 items of Octreotide acetate over the last 12 months at a cost of £6,063 to the NHS. This is 125.3% above the national average prescribing rate. Octreotide acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 14 |
|---|---|
| Total Quantity | 830 |
| Total NHS Cost | £6,063 |
| Presentations | 1 different forms |
| vs National Average | +125.3% |
Octreotide acetate Prescribing Comparison
| This practice | 14 items |
|---|---|
| National average per practice | 6 items |
| Difference | +125.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.